HEADER CYTOKINE 29-OCT-23 8USS
TITLE IL17A COMPLEXED TO COMPOUND 7
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: INTERLEUKIN-17A;
COMPND 3 CHAIN: A;
COMPND 4 SYNONYM: IL-17,IL-17A,CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED ANTIGEN 8,
COMPND 5 CTLA-8;
COMPND 6 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: IL17A, CTLA8, IL17;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS HOMODIMER, INHIBITOR, DEL, CYTOKINE
EXPDTA X-RAY DIFFRACTION
AUTHOR M.A.ARGIRIADI,A.L.RAMOS
REVDAT 4 09-OCT-24 8USS 1 REMARK
REVDAT 3 01-MAY-24 8USS 1 JRNL
REVDAT 2 17-APR-24 8USS 1 JRNL
REVDAT 1 03-APR-24 8USS 0
JRNL AUTH A.L.RAMOS,E.R.GOEDKEN,K.E.FRANK,M.A.ARGIRIADI,S.BAZZAZ,
JRNL AUTH 2 Z.BIAN,J.T.C.BROWN,P.A.CENTRELLA,H.J.CHEN,J.S.DISCH,
JRNL AUTH 3 P.L.DONNER,D.B.DUIGNAN,D.GIKUNJU,S.N.GRESZLER,M.A.GUIE,
JRNL AUTH 4 S.HABESHIAN,H.E.HARTL,C.D.HEIN,C.W.HUTCHINS,R.JETSON,
JRNL AUTH 5 A.D.KEEFE,H.KHAN,H.Q.LI,A.OLSZEWSKI,B.J.ORTIZ CARDONA,
JRNL AUTH 6 A.OSUMA,S.C.PANCHAL,R.PHELAN,W.QIU,J.B.SHOTWELL,A.SHRESTHA,
JRNL AUTH 7 M.SRIKUMARAN,Z.SU,C.SUN,A.K.UPADHYAY,M.D.WOOD,H.WU,R.ZHANG,
JRNL AUTH 8 Y.ZHANG,G.ZHAO,H.ZHU,M.P.WEBSTER
JRNL TITL DISCOVERY OF SMALL MOLECULE INTERLEUKIN 17A INHIBITORS WITH
JRNL TITL 2 NOVEL BINDING MODE AND STOICHIOMETRY: OPTIMIZATION OF
JRNL TITL 3 DNA-ENCODED CHEMICAL LIBRARY HITS TO IN VIVO ACTIVE
JRNL TITL 4 COMPOUNDS.
JRNL REF J.MED.CHEM. V. 67 6456 2024
JRNL REFN ISSN 0022-2623
JRNL PMID 38574366
JRNL DOI 10.1021/ACS.JMEDCHEM.3C02397
REMARK 2
REMARK 2 RESOLUTION. 1.47 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : PHENIX 1.20.1_4487
REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN
REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE,
REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER,
REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY,
REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON,
REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI,
REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT
REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART
REMARK 3
REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.47
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 15.78
REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.320
REMARK 3 COMPLETENESS FOR RANGE (%) : 86.3
REMARK 3 NUMBER OF REFLECTIONS : 21830
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 R VALUE (WORKING + TEST SET) : 0.222
REMARK 3 R VALUE (WORKING SET) : 0.221
REMARK 3 FREE R VALUE : 0.236
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.820
REMARK 3 FREE R VALUE TEST SET COUNT : 1053
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS).
REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE
REMARK 3 1 15.7800 - 2.9400 1.00 3165 159 0.2080 0.2107
REMARK 3 2 2.9400 - 2.3300 1.00 3038 159 0.2211 0.2475
REMARK 3 3 2.3300 - 2.0400 1.00 3004 153 0.2214 0.2319
REMARK 3 4 2.0400 - 1.8500 1.00 2988 144 0.2327 0.2509
REMARK 3 5 1.8500 - 1.7200 0.97 2871 164 0.2469 0.2828
REMARK 3 6 1.7200 - 1.6200 0.85 2509 120 0.2452 0.2830
REMARK 3 7 1.6200 - 1.5400 0.67 1972 99 0.2605 0.3017
REMARK 3 8 1.5400 - 1.4700 0.41 1230 55 0.3343 0.3407
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL
REMARK 3 SOLVENT RADIUS : 1.10
REMARK 3 SHRINKAGE RADIUS : 0.90
REMARK 3 K_SOL : NULL
REMARK 3 B_SOL : NULL
REMARK 3
REMARK 3 ERROR ESTIMATES.
REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.181
REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 27.743
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 20.53
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.22
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : NULL
REMARK 3 B22 (A**2) : NULL
REMARK 3 B33 (A**2) : NULL
REMARK 3 B12 (A**2) : NULL
REMARK 3 B13 (A**2) : NULL
REMARK 3 B23 (A**2) : NULL
REMARK 3
REMARK 3 TWINNING INFORMATION.
REMARK 3 FRACTION: NULL
REMARK 3 OPERATOR: NULL
REMARK 3
REMARK 3 DEVIATIONS FROM IDEAL VALUES.
REMARK 3 RMSD COUNT
REMARK 3 BOND : 0.023 914
REMARK 3 ANGLE : 2.092 1254
REMARK 3 CHIRALITY : 0.150 136
REMARK 3 PLANARITY : 0.015 170
REMARK 3 DIHEDRAL : 15.287 327
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 NCS DETAILS
REMARK 3 NUMBER OF NCS GROUPS : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 8USS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-OCT-23.
REMARK 100 THE DEPOSITION ID IS D_1000278569.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 14-FEB-18
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : NULL
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : APS
REMARK 200 BEAMLINE : 17-ID
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.00
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : PIXEL
REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : AUTOPROC
REMARK 200 DATA SCALING SOFTWARE : AUTOPROC
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21942
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.465
REMARK 200 RESOLUTION RANGE LOW (A) : 78.700
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 85.6
REMARK 200 DATA REDUNDANCY : 5.100
REMARK 200 R MERGE (I) : NULL
REMARK 200 R SYM (I) : 0.04000
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 21.9000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.47
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.53
REMARK 200 COMPLETENESS FOR SHELL (%) : NULL
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : 0.26900
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 50.46
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.48
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 15% W/V PEG 8K, 0.2 M MGCL2, 0.1 M
REMARK 280 TRIS PH 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 296K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,-Y,Z
REMARK 290 3555 -X,Y,-Z
REMARK 290 4555 X,-Y,-Z
REMARK 290 5555 X+1/2,Y+1/2,Z+1/2
REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2
REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2
REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 18.30000
REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 25.19000
REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 78.68000
REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 18.30000
REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 25.19000
REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 78.68000
REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 18.30000
REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 25.19000
REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 78.68000
REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 18.30000
REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 25.19000
REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 78.68000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 375
REMARK 375 SPECIAL POSITION
REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS
REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL
REMARK 375 POSITIONS.
REMARK 375
REMARK 375 ATOM RES CSSEQI
REMARK 375 HOH A 310 LIES ON A SPECIAL POSITION.
REMARK 375 HOH A 322 LIES ON A SPECIAL POSITION.
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 GLY A 29
REMARK 465 SER A 30
REMARK 465 ALA A 31
REMARK 465 MET A 32
REMARK 465 ALA A 33
REMARK 465 PRO A 34
REMARK 465 ASN A 35
REMARK 465 SER A 36
REMARK 465 GLU A 37
REMARK 465 ASP A 38
REMARK 465 LYS A 39
REMARK 465 ASN A 40
REMARK 465 PHE A 41
REMARK 465 PRO A 42
REMARK 465 HIS A 128
REMARK 465 SER A 129
REMARK 465 PRO A 130
REMARK 465 ASN A 131
REMARK 465 SER A 132
REMARK 465 PHE A 133
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 ARG A 43 CG CD NE CZ NH1 NH2
REMARK 470 THR A 44 OG1 CG2
REMARK 470 VAL A 45 CG1 CG2
REMARK 470 HIS A 52 CG ND1 CD2 CE1 NE2
REMARK 470 ARG A 62 CG CD NE CZ NH1 NH2
REMARK 470 GLU A 125 CG CD OE1 OE2
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION
REMARK 500 ASP A 81 C PRO A 82 N 0.138
REMARK 500 PRO A 86 N PRO A 86 CA 0.199
REMARK 500 PRO A 114 N PRO A 114 CA 0.175
REMARK 500 GLU A 125 C PRO A 126 N 0.150
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3
REMARK 500 PRO A 82 C - N - CA ANGL. DEV. = 10.4 DEGREES
REMARK 500 PRO A 114 C - N - CA ANGL. DEV. = 13.2 DEGREES
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 VAL A 45 -125.34 -110.03
REMARK 500 ASN A 50 -157.49 -151.83
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY
REMARK 500
REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY
REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER
REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME;
REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 500 I=INSERTION CODE).
REMARK 500
REMARK 500 M RES CSSEQI ANGLE
REMARK 500 THR A 148 11.62
REMARK 500 THR A 148 13.34
REMARK 500
REMARK 500 REMARK: NULL
DBREF 8USS A 34 155 UNP Q16552 IL17_HUMAN 34 155
SEQADV 8USS GLY A 29 UNP Q16552 EXPRESSION TAG
SEQADV 8USS SER A 30 UNP Q16552 EXPRESSION TAG
SEQADV 8USS ALA A 31 UNP Q16552 EXPRESSION TAG
SEQADV 8USS MET A 32 UNP Q16552 EXPRESSION TAG
SEQADV 8USS ALA A 33 UNP Q16552 EXPRESSION TAG
SEQADV 8USS SER A 129 UNP Q16552 CYS 129 ENGINEERED MUTATION
SEQRES 1 A 127 GLY SER ALA MET ALA PRO ASN SER GLU ASP LYS ASN PHE
SEQRES 2 A 127 PRO ARG THR VAL MET VAL ASN LEU ASN ILE HIS ASN ARG
SEQRES 3 A 127 ASN THR ASN THR ASN PRO LYS ARG SER SER ASP TYR TYR
SEQRES 4 A 127 ASN ARG SER THR SER PRO TRP ASN LEU HIS ARG ASN GLU
SEQRES 5 A 127 ASP PRO GLU ARG TYR PRO SER VAL ILE TRP GLU ALA LYS
SEQRES 6 A 127 CYS ARG HIS LEU GLY CYS ILE ASN ALA ASP GLY ASN VAL
SEQRES 7 A 127 ASP TYR HIS MET ASN SER VAL PRO ILE GLN GLN GLU ILE
SEQRES 8 A 127 LEU VAL LEU ARG ARG GLU PRO PRO HIS SER PRO ASN SER
SEQRES 9 A 127 PHE ARG LEU GLU LYS ILE LEU VAL SER VAL GLY CYS THR
SEQRES 10 A 127 CYS VAL THR PRO ILE VAL HIS HIS VAL ALA
HET XCW A 201 59
HET CL A 202 1
HETNAM XCW 4,5-DICHLORO-N-[(1S)-1-CYCLOHEXYL-2-{[(3S)-5-METHYL-4-
HETNAM 2 XCW OXO-2,3,4,5-TETRAHYDRO-1,5-BENZOXAZEPIN-3-YL]AMINO}-2-
HETNAM 3 XCW OXOETHYL]-1H-PYRROLE-2-CARBOXAMIDE
HETNAM CL CHLORIDE ION
FORMUL 2 XCW C23 H26 CL2 N4 O4
FORMUL 3 CL CL 1-
FORMUL 4 HOH *72(H2 O)
HELIX 1 AA1 ASN A 50 ARG A 54 5 5
HELIX 2 AA2 ASN A 59 ASN A 68 1 10
SHEET 1 AA1 2 TRP A 74 GLU A 80 0
SHEET 2 AA1 2 VAL A 88 CYS A 94 -1 O LYS A 93 N ASN A 75
SHEET 1 AA2 3 ARG A 84 TYR A 85 0
SHEET 2 AA2 3 ASN A 111 ARG A 123 -1 O LEU A 122 N TYR A 85
SHEET 3 AA2 3 LEU A 135 VAL A 147 -1 O GLU A 136 N VAL A 121
SHEET 1 AA3 2 CYS A 99 ILE A 100 0
SHEET 2 AA3 2 VAL A 106 ASP A 107 -1 O ASP A 107 N CYS A 99
SSBOND 1 CYS A 94 CYS A 144 1555 1555 2.16
SSBOND 2 CYS A 99 CYS A 146 1555 1555 2.12
CISPEP 1 TYR A 85 PRO A 86 0 3.33
CISPEP 2 GLU A 125 PRO A 126 0 -0.79
CRYST1 36.600 50.380 157.360 90.00 90.00 90.00 I 2 2 2 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.027322 0.000000 0.000000 0.00000
SCALE2 0.000000 0.019849 0.000000 0.00000
SCALE3 0.000000 0.000000 0.006355 0.00000